Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for pati
Similar Posts
“Peter Michael, M.D. – 711299 – 06/18/2025
Clinical InvestigatorFood Business Karison Foods & Snacks Inc Recalls ‘PANJIRI’, ‘ALSI PINNI’, ‘PUNJABI PINNI’, ‘BESAN LADDOO’, and ‘NO SUGAR ADDED BESAN LADDOO’ Due to Undeclared Milk Allergen
Karison Foods & Snacks Inc of Port Washington, NY 11050 is recalling 12 oz containers of ‘PANJIRI’, ‘ALSI PINNI’, ‘PUNJABI PINNI’, ‘BESAN LADDOO’, and ‘NO SUGAR ADDED BESAN LADDOO’ due to undeclared milk allergenBaxter Oncology GmbH – 08/27/2024
Baxter Oncology GmbH – 08/27/2024. Country: Germany. Record Type: 483FDA’s Labeling Resources for Human Prescription Drugs
FDA’s Labeling Resources for Human Prescription DrugsAlert: Siemens Healthineers Issues Correction for 3 Tesla MRI Systems
Siemens Healthineers is correcting 3 Tesla MRI systems including MAGNETOM and BioGraph mMR due to the potential for ice blockage in the magnet venting systemYangzhou Yulou Paper Products Co., Ltd. – 710907 – 09/09/2025
CGMP/Finished Pharmaceuticals/Adulterated
